Massive Selling Leaves Few Unscathed; AstraZeneca, NextEra, T-Mobile In Focus

Selling accelerated in the market and few things were spared as the major indexes lost support at moving averages. It was an expectation breaker given the strength of the prior day. AstraZeneca still managed to breakout of a flat base. NextEra joined utilities in a rally with a follow-up to its move above its 50-day line Thursday. T-Mobile also had a nice follow-up to its 50-day line test and retook a flat-base buy point at 182.67. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.